Stephanie Titze1, Matthias Schmid2, Anna Köttgen3, Martin Busch4, Jürgen Floege5, Christoph Wanner6, Florian Kronenberg7, Kai-Uwe Eckardt1. 1. Department of Nephrology and Hypertension, Friedrich-Alexander University Erlangen-Nürnberg, FAU, Erlangen, Germany. 2. Department of Medical Informatics, Biometry and Epidemiology, University of Erlangen-Nürnberg, Erlangen, Germany Department of Medical Biometry, Informatics, and Epidemiology, (IMBIE), University of Bonn, Bonn, Germany. 3. Division of Nephrology, University of Freiburg, Freiburg, Germany. 4. Department of Internal Medicine III, University Hospital Jena, Jena, Germany. 5. Department of Nephrology and Clinical Immunology, RWTH Aachen University, Aachen, Germany. 6. Division of Nephrology, Department of Medicine, University Hospital of Würzburg, Würzburg, Germany. 7. Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria.
Abstract
BACKGROUND: A main challenge for targeting chronic kidney disease (CKD) is the heterogeneity of its causes, co-morbidities and outcomes. Patients under nephrological care represent an important reference population, but knowledge about their characteristics is limited. METHODS: We enrolled 5217 carefully phenotyped patients with moderate CKD [estimated glomerular filtration rate (eGFR) 30-60 mL/min per 1.73 m(2) or overt proteinuria at higher eGFR] under routine care of nephrologists into the German Chronic Kidney Disease (GCKD) study, thereby establishing the currently worldwide largest CKD cohort. RESULTS: The cohort has 60% men, a mean age (±SD) of 60 ± 12 years, a mean eGFR of 47 ± 17 mL/min per 1.73 m(2) and a median (IQR) urinary albumin/creatinine ratio of 51 (9-392) mg/g. Assessment of causes of CKD revealed a high degree of uncertainty, with the leading cause unknown in 20% and frequent suspicion of multifactorial pathogenesis. Thirty-five per cent of patients had diabetes, but only 15% were considered to have diabetic nephropathy. Cardiovascular disease prevalence was high (32%, excluding hypertension); prevalent risk factors included smoking (59% current or former smokers) and obesity (43% with BMI >30). Despite widespread use of anti-hypertensive medication, only 52% of the cohort had an office blood pressure <140/90 mmHg. Family histories for cardiovascular events (39%) and renal disease (28%) suggest familial aggregation. CONCLUSIONS: Patients with moderate CKD under specialist care have a high disease burden. Improved diagnostic accuracy, rigorous management of risk factors and unravelling of the genetic predisposition may represent strategies for improving prognosis.
BACKGROUND: A main challenge for targeting chronic kidney disease (CKD) is the heterogeneity of its causes, co-morbidities and outcomes. Patients under nephrological care represent an important reference population, but knowledge about their characteristics is limited. METHODS: We enrolled 5217 carefully phenotyped patients with moderate CKD [estimated glomerular filtration rate (eGFR) 30-60 mL/min per 1.73 m(2) or overt proteinuria at higher eGFR] under routine care of nephrologists into the German Chronic Kidney Disease (GCKD) study, thereby establishing the currently worldwide largest CKD cohort. RESULTS: The cohort has 60% men, a mean age (±SD) of 60 ± 12 years, a mean eGFR of 47 ± 17 mL/min per 1.73 m(2) and a median (IQR) urinary albumin/creatinine ratio of 51 (9-392) mg/g. Assessment of causes of CKD revealed a high degree of uncertainty, with the leading cause unknown in 20% and frequent suspicion of multifactorial pathogenesis. Thirty-five per cent of patients had diabetes, but only 15% were considered to have diabetic nephropathy. Cardiovascular disease prevalence was high (32%, excluding hypertension); prevalent risk factors included smoking (59% current or former smokers) and obesity (43% with BMI >30). Despite widespread use of anti-hypertensive medication, only 52% of the cohort had an office blood pressure <140/90 mmHg. Family histories for cardiovascular events (39%) and renal disease (28%) suggest familial aggregation. CONCLUSIONS:Patients with moderate CKD under specialist care have a high disease burden. Improved diagnostic accuracy, rigorous management of risk factors and unravelling of the genetic predisposition may represent strategies for improving prognosis.
Authors: Markus P Schneider; Ulrike Raff; Christoph Kopp; Johannes B Scheppach; Sebastian Toncar; Christoph Wanner; Georg Schlieper; Turgay Saritas; Jürgen Floege; Matthias Schmid; Anna Birukov; Anke Dahlmann; Peter Linz; Rolf Janka; Michael Uder; Roland E Schmieder; Jens M Titze; Kai-Uwe Eckardt Journal: J Am Soc Nephrol Date: 2017-02-02 Impact factor: 10.121
Authors: Charlotte Osafo; Yemi Raheem Raji; David Burke; Bamidele O Tayo; Nicki Tiffin; Marva M Moxey-Mims; Rebekah S Rasooly; Paul L Kimmel; Akinlolu Ojo; Dwomoa Adu; Rulan S Parekh Journal: Clin J Am Soc Nephrol Date: 2015-07-02 Impact factor: 8.237
Authors: Michael Altenbuchinger; Antoine Weihs; John Quackenbush; Hans Jörgen Grabe; Helena U Zacharias Journal: Biochim Biophys Acta Gene Regul Mech Date: 2019-10-19 Impact factor: 4.490
Authors: Markus P Schneider; Silvia Hübner; Stephanie I Titze; Matthias Schmid; Jennifer Nadal; Georg Schlieper; Martin Busch; Seema Baid-Agrawal; Vera Krane; Christoph Wanner; Florian Kronenberg; Kai-Uwe Eckardt Journal: Kidney Int Date: 2015-09-02 Impact factor: 10.612
Authors: Peggy Sekula; Yong Li; Horia C Stanescu; Matthias Wuttke; Arif B Ekici; Detlef Bockenhauer; Gerd Walz; Stephen H Powis; Jan T Kielstein; Paul Brenchley; Kai-Uwe Eckardt; Florian Kronenberg; Robert Kleta; Anna Köttgen Journal: Nephrol Dial Transplant Date: 2016-02-04 Impact factor: 5.992
Authors: Kai-Uwe Eckardt; Seth L Alper; Corinne Antignac; Anthony J Bleyer; Dominique Chauveau; Karin Dahan; Constantinos Deltas; Andrew Hosking; Stanislav Kmoch; Luca Rampoldi; Michael Wiesener; Matthias T Wolf; Olivier Devuyst Journal: Kidney Int Date: 2015-03-04 Impact factor: 10.612